Cabozantinib S-Malate
Drug timelines are a Plus or Pro feature.
17 regulatory and trial events tracked for Cabozantinib S-Malate, covering 2014-09-25 to 2026-08-14. Get the full timeline:
Most recent: FDA Approved: CABOZANTINIB S-MALATE — Original Application (MSN)